Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Forecast, price target & analysts
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Target price 2026 - Analyst rating & recommendation
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Classifications & Recommendation
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Price Target
| Target Price | $336.60 |
| Price | $387.54 |
| Deviation |
13.14%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Bio-Rad Laboratories Inc. - Ordinary Shares - Class A 2027 .
The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A target price is $336.60.
This is
13.14%
register free of charge
$409.50
5.67%
register free of charge
$318.15
17.91%
register free of charge
|
|
| A rating was issued by 10 analysts: 5 Analysts recommend Bio-Rad Laboratories Inc. - Ordinary Shares - Class A to buy, 4 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock has an average upside potential 2027 of
13.14%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.58 | 2.61 |
| 0.65% | 1.00% | |
| Net Margin | 29.42% | 9.98% |
| 140.94% | 66.07% |
7 Analysts have issued a sales forecast Bio-Rad Laboratories Inc. - Ordinary Shares - Class A 2026 . The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
7 Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Analysts have issued a net profit forecast 2026. The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 27.85 | 9.74 |
| 142.61% | 65.03% | |
| P/E | 39.80 | |
| EV/Sales | 3.83 |
7 Analysts have issued a Bio-Rad Laboratories Inc. - Ordinary Shares - Class A forecast for earnings per share. The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A...
Current Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | May 15 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | May 01 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Apr 07 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
May 15 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
May 01 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Apr 07 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
